NeoGenomics, Inc.: NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference

FT MYERS, FL / ACCESSWIRE / May 5, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that

Related Keywords

Fort Myers ,Florida ,United States ,Georgia ,Nevada ,Tampa ,North Carolina ,United Kingdom ,Texas ,Research Triangle Park ,Atlanta ,California ,San Diego ,Arizona ,Tennessee ,Singapore ,Phoenix ,Houston ,Aliso Viejo ,Cambridge ,Cambridgeshire ,Switzerland ,Charlie Eidson ,Las Vegas ,Doug Brown ,Company Annual Report On Form ,Corporate Development ,Neogenomics Inc ,Company Pharma Services Division ,Nasdaq ,Pharma Services Division ,Privacy Practices ,Annual Report ,Corporate Development Officer ,Investor Relations ,Neogenomics ,Articipate ,Sofa ,Securities ,022 ,Healthcare ,Conference ,